Latest Regenerative September 22, 2025 News

Japanese officials move to update guidelines as researchers explore stem cell-derived human embryos for infertility and genetic studies.
A new clinical trial in Texas will evaluate stem cell therapy’s potential to improve outcomes for adults with chronic TBI.
Gameto’s latest funding will accelerate late-stage clinical trials and regulatory efforts for its stem cell-based fertility therapy.
The latest additions aim to support clinicians treating smaller wounds, enhancing flexibility and workflow in surgical wound care.
Interim study results highlight Remplir’s consistent safety and effectiveness in nerve repair, supporting further clinical and regulatory efforts.
New peer-reviewed review argues that Wharton's Jelly derived mesenchymal stem cells offer a novel, non-invasive option for many regenerative therapies.

Stay updated on Regenerative Medicine